Earnings Call Insights: AbbVie Inc. (ABBV) Q1 2025
Management View
- CEO Rob Michael highlighted an excellent start to 2025, with adjusted EPS of $2.46, exceeding the guidance midpoint by $0.10, and total revenues surpassing $13.3 billion, driven by a 21% growth in the ex-Humira platform. He announced a $0.10 increase